Bayer joins the Blister Pack Collective

PA Consulting (PA), the company bringing ingenuity to life, and PulPac, the Swedish R&D and IP company behind Dry Molded Fiber (DMF), announced the Consumer Health division of Bayer has joined the Blister Pack Collective to reduce single-use plastics in tablet packs.

The Blister Pack Collective brings together pharma, consumer health, and FMCG businesses to accelerate progress towards a world of more sustainable tablet packs, free from problem plastics like PVC. PA and PulPac have seeded the collective and developed the underlying technology needed to bring a functioning DMF tablet blister pack to life. The adoption of Dry Molded Fiber tablet packs provides an opportunity to cut back on the more than 100,000 tonnes of plastic medicine packaging used every year.

Dry Molded Fiber technology minimizes CO₂ emissions – leaving up to an 80% lower CO2 footprint than plastic – and requires minimal water usage. It enables the production of versatile tablet packs that are comparable to PVC packs in terms of design and tablet count.

Tony Perrotta, Pulpac Partnership Lead at PA Consulting, said: “PA and PulPac formed the Blister Pack Collective to accelerate the progress to reduce single-use plastics, especially problem plastics like PVC, in over-the-counter, prescription drugs, nutraceuticals, and confectionary items. We are delighted to join forces with leading brand partners like Bayer to accelerate development and create a global impact.”

Jesse DelGigante, Director Global Packaging Innovation at Bayer Consumer Health, added: “We have a bold commitment to transform 100% of our packaging to be recyclable or renewable by 2030 and have committed to invest €100 million investment in changing how our products are made and consumed. Achieving this will require working with the best partners and we are proud to be a part of the Blister Pack Collective as we work to make a real impact for sustainability.”